Aceso Life Science Group Ltd
HKEX:474
Relative Value
The Relative Value of one Aceso Life Science Group Ltd stock under the Base Case scenario is 0.07 HKD. Compared to the current market price of 0.155 HKD, Aceso Life Science Group Ltd is Overvalued by 55%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
Aceso Life Science Group Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
HK |
A
|
Aceso Life Science Group Ltd
HKEX:474
|
1.1B HKD | 4.3 | -2.7 | 78.7 | 78.7 | |
US |
American Express Co
NYSE:AXP
|
167.3B USD | 2.5 | 18.9 | 22.8 | 26.1 | ||
US |
Capital One Financial Corp
NYSE:COF
|
54.3B USD | 1.5 | 11.1 | 32.4 | 0 | ||
IN |
Bajaj Finance Ltd
NSE:BAJFINANCE
|
4.2T INR | 8.9 | 39.2 | 28.1 | 28.2 | ||
US |
Discover Financial Services
NYSE:DFS
|
31.3B USD | 1.9 | 14.2 | 113 | 0 | ||
US |
Synchrony Financial
NYSE:SYF
|
18B USD | 1 | 6.2 | 74.4 | 0 | ||
IN |
Cholamandalam Investment and Finance Company Ltd
NSE:CHOLAFIN
|
1.1T INR | 6.2 | 33.3 | 41.2 | 42.3 | ||
US |
Santander Consumer USA Holdings Inc
NYSE:SC
|
12.7B USD | 1.6 | 4.1 | 8.5 | 12.2 | ||
US |
Ally Financial Inc
NYSE:ALLY
|
11.7B USD | 1.3 | 15.7 | 23 | 0 | ||
IN |
Shriram Finance Ltd
NSE:SHRIRAMFIN
|
968.3B INR | 2.8 | 14.6 | 18.2 | 19.3 | ||
BR |
Creditaqui Financeira SA - Credito Financiamento e Investimento
BOVESPA:MERC3
|
56B BRL | 1 121.8 | -15 581.4 | 0 | 0 |